Novanta Inc

Novanta Inc

NOVT

Get informed when a big investor buys or sells

+ Follow
Market Cap$5.32B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Novanta IncNovanta Inc88.6-4%5.60.2
$194.00

Target Price by Analysts

37.8% upsideNovanta Target Price DetailsTarget Price
$29.94

Current Fair Value

78.7% downside

Overvalued by 78.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$5.32 Billion
Enterprise Value$4.89 Billion
Dividend Yield$- (-)
Earnings per Share$1.47
Beta1.72
Outstanding Shares41,009,000

Return

Return on Equity3.82%ROE
Return on Assets2.89%
Return on Invested Capital5.35%

Valuation & Multiples

P/E Ratio88.55P/E Ratio
PEG49.51PEG
Price to Sales5.63Price to Sales
Price to Book Ratio3.61Price to Book Ratio
Enterprise Value to Revenue4.75
Enterprise Value to EBIT48.24
Enterprise Value to Net Income79
Total Debt to Enterprise0.06
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 5, 2026
EPS Estimate
$0.83
Average shareholder expectation
Revenue Estimate
$262.30 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$0.97
Average shareholder expectation
Revenue Estimate
$301.02 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 1958.31%
Total Calls-▼ 100.00%
Total Puts9,600▼ 99.61%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %6.13%▼ 104.46%
Total Invested$357.13M▼ 95.14%
Investors Holding64▼ 344.00%

ESG Score

No data

About Novanta Inc

3,000 employees
CEO: Matthijs Glastra

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...